Astellas Pharma reported JPY317.61B in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Astellas Pharma 4503:JP JPY 317.61B 24.69B
Chugai Pharma 4519:JP JPY 156.19B 399M
Daiichi Sankyo 4568:JP JPY 242.71B 37.19B
Eisai 4523:JP JPY 129.23B 7.63B
Kyowa Hakko Kirin 4151:JP JPY 77.74B 1.44B
M3 2413:JP JPY 31.91B 1.42B
Otsuka Holdings 4578:JP JPY 299.08B 13.03B
Shionogi 4507:JP JPY 64.52B 5.62B
Sumitomo Dainippon 4506:JP JPY 112.63B 1.19B
Takeda 4502:JP JPY 696.86B 17.28B
Terumo 4543:JP JPY 105.36B 3.72B